Mesenchymal stem cell therapy following acute MI - Mesenchymal stem cell therapy following acute MI

Description:

The goal of the trial was to evaluate the safety and efficacy of different doses of allogeneic bone-marrow derived mesenchymal stem cell (MSC) therapy compared with placebo in post-acute myocardial infarction (MI) patients.